UroGen Pharma Ltd. (URGN)
UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead product candidate is UGN-102, which is in Phase III clinical trials for the treatment of several forms of non-muscle invasive urothelial cancer that include low-grade upper tract urothelial carcinoma and low-grade non-muscle invasive bladder cancer. It is also developing UGN-301 for the treatment of high-grade non-muscle invasive bladder cancer. The company has a license agreement with Allergan Pharmaceuticals International Limited for developing and commercializing pharmaceutical products that contain RTGel and clostridial toxins; Agenus Inc. to develop, make, use, sell, import, and commercialize products of Agenus for the treatment of cancers of the urinary tract via intravesical delivery; and strategic research collaboration with MD Anderson to advance investigational treatment for high-grade bladder cancer. UroGen Pharma Ltd. was incorporated in 2004 and is based in Princeton, New Jersey.
$583.28M
Ms. Elizabeth A. Barrett
195.00
Princeton, NJ
May 04, 2017
-4.48
$-3.09
0.75
3.04
-149.52%
-2.74
0.00
-2.15
5.38
2.35
-113.70%
106.56%
Similar stocks (18)
Edgewise Therapeutics, Inc.
EWTX
Tyra Biosciences, Inc.
TYRA
Erasca, Inc.
ERAS
Scholar Rock Holding Corporation
SRRK
Celcuity Inc.
CELC
Eliem Therapeutics, Inc.
ELYM
PureTech Health plc
PRTC
C4 Therapeutics, Inc.
CCCC
PepGen Inc.
PEPG
Inhibrx, Inc.
INBX
Compass Therapeutics, Inc.
CMPX
Generation Bio Co.
GBIO
Vigil Neuroscience, Inc.
VIGL
Ovid Therapeutics Inc.
OVID
Ikena Oncology, Inc.
IKNA
Kronos Bio, Inc.
KRON
Protara Therapeutics, Inc.
TARA
Xilio Therapeutics, Inc.
XLO
ETF Exposure (23)
ARK Israel Innovative Technology ETF
IZRL
1.77%
BlueStar Israel Technology ETF
ITEQ
0.6%
iShares Micro-Cap ETF
IWC
0.12649%
Invesco Nasdaq Biotechnology ETF
IBBQ
0.048%
iShares Biotechnology ETF
IBB
0.04415%
Vanguard U.S. Momentum Factor ETF
VFMO
0.04%
Vanguard Russell 2000 Growth Index Fund
VTWG
0.03%
SPDR S&P International Small Cap ETF
GWX
0.029237%
iShares Russell 2000 Growth ETF
IWO
0.02845%
Vanguard Russell 2000 Index Fund
VTWO
0.02%
iShares Russell 2000 ETF
IWM
0.01829%
ProShares Ultra Nasdaq Biotechnology
BIB
0.014318828774680312%
Vanguard Russell 2000 Value Index Fund
VTWV
0.01%
iShares Russell 2000 Value ETF
IWN
0.00816%
SPDR Portfolio Developed World ex-US ETF
SPDW
0.007448%
ProShares Ultra Russell2000
UWM
0.006986777221755618%
Fidelity MSCI Health Care Index ETF
FHLC
0.00577357%
ALPS Medical Breakthroughs ETF
SBIO
0.0035%
ProShares UltraPro Russell2000
URTY
0.0034425158369235974%
ProShares Hedge Replication ETF
HDG
0.0029084103672351435%
iShares Russell 3000 ETF
IWV
9.1e-4%
Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF
GSSC
0%
Vanguard Russell 3000 Index Fund
VTHR
0%
Similar stocks (18)
Edgewise Therapeutics, Inc.
EWTX
Tyra Biosciences, Inc.
TYRA
Erasca, Inc.
ERAS
Scholar Rock Holding Corporation
SRRK
Celcuity Inc.
CELC
Eliem Therapeutics, Inc.
ELYM
PureTech Health plc
PRTC
C4 Therapeutics, Inc.
CCCC
PepGen Inc.
PEPG
Inhibrx, Inc.
INBX
Compass Therapeutics, Inc.
CMPX
Generation Bio Co.
GBIO
Vigil Neuroscience, Inc.
VIGL
Ovid Therapeutics Inc.
OVID
Ikena Oncology, Inc.
IKNA
Kronos Bio, Inc.
KRON
Protara Therapeutics, Inc.
TARA
Xilio Therapeutics, Inc.
XLO
ETF Exposure (23)
ARK Israel Innovative Technology ETF
IZRL
1.77%
BlueStar Israel Technology ETF
ITEQ
0.6%
iShares Micro-Cap ETF
IWC
0.12649%
Invesco Nasdaq Biotechnology ETF
IBBQ
0.048%
iShares Biotechnology ETF
IBB
0.04415%
Vanguard U.S. Momentum Factor ETF
VFMO
0.04%
Vanguard Russell 2000 Growth Index Fund
VTWG
0.03%
SPDR S&P International Small Cap ETF
GWX
0.029237%
iShares Russell 2000 Growth ETF
IWO
0.02845%
Vanguard Russell 2000 Index Fund
VTWO
0.02%
iShares Russell 2000 ETF
IWM
0.01829%
ProShares Ultra Nasdaq Biotechnology
BIB
0.014318828774680312%
Vanguard Russell 2000 Value Index Fund
VTWV
0.01%
iShares Russell 2000 Value ETF
IWN
0.00816%
SPDR Portfolio Developed World ex-US ETF
SPDW
0.007448%
ProShares Ultra Russell2000
UWM
0.006986777221755618%
Fidelity MSCI Health Care Index ETF
FHLC
0.00577357%
ALPS Medical Breakthroughs ETF
SBIO
0.0035%
ProShares UltraPro Russell2000
URTY
0.0034425158369235974%
ProShares Hedge Replication ETF
HDG
0.0029084103672351435%
iShares Russell 3000 ETF
IWV
9.1e-4%
Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF
GSSC
0%
Vanguard Russell 3000 Index Fund
VTHR
0%